Low-dose ketamine as an adjuvant for postoperative pain control in postpartum women with low pain threshold: a randomized controlled trial
ISSN (print) 1726-9806     ISSN (online) 1818-474X
2024-3
PDF_2024-3_27-37 (Russian)

Keywords

ketamine
pain threshold
cesarean section
analgesia

How to Cite

1.
Shindyapina N.V., Marshalov D.V., Shifman E.M., Kuligin A.V. Low-dose ketamine as an adjuvant for postoperative pain control in postpartum women with low pain threshold: a randomized controlled trial. Annals of Critical Care. 2024;(3):27-37. doi:10.21320/1818-474X-2024-3-27-37

Statistic

Abstract Views: 863
PDF_2024-3_27-37 (Russian) Downloads: 377
Statistic from 01.07.2024

Language

English Русский

Social Networks

Abstract

INTRODUCTION: One in five women experiences high-intensity pain after a cesarean section. OBJECTIVE: Evaluation of the effectiveness of low-dose ketamine in the prevention of high-intensity pain in women with a low pain threshold after cesarean section. MATERIALS AND METHODS: A randomized controlled trial (RCT) was conducted on 90 women who underwent elective cesarean section (CS) under spinal anesthesia. Women were stratified into two categories: normal and low pain threshold. Within each subgroup, the patients were randomized into three groups: intraoperative intravenous administration of ketamine at a dose of 0.25 mg/kg; 0.5 mg/kg, and control group. The time to first request for analgesia and total tramadol dose during the first postoperative day were recorded. The frequency of adverse reactions was analyzed. RESULTS: The median and interquartile range (IQR) for mean pain intensity in the first day, pain on movement, and pain at rest 24 hours after CS were significantly higher in the control group compared to the ketamine groups (p < 0.001). Time to first requirement of analgesia increased in the ketamine 0.5 mg/kg group 190.0 [175.0–195.0] minutes compared with the control group 130.0 [130.0–140.0] minutes with p < 0.001. Tramadol consumption on the first day was significantly lower in the ketamine groups compared with the control groups (p < 0.001). Between-group statistically significant differences in the studied pain indicators in the ketamine groups (0.5 and 0.25 mg/kg) were not observed in either patients with a normal or low pain threshold (p > 0.005). Adverse effects (distorted reality and visual impairment) at the minimum dosage of 0.25 mg/kg were observed exclusively in patients with a normal pain threshold. CONCLUSIONS: For patients with an initially low pain threshold, the use of ketamine at a dose of 0.25 mg/kg has the best efficacy and safety profile.

PDF_2024-3_27-37 (Russian)

Full-text of the article is available for this locale: Russian.

References

  1. Kan A. Classical Cesarean Section. The Surgery Journal. 2020; 6(2): 98–103. DOI: 10.1055/s-0039-3402072
  2. Gamez B.H., Habib A.S. Predicting Severity of Acute Pain After Cesarean Delivery: A Narrative Review. Anesthesia & Analgesia. 2018; 126(5): 1606–14. DOI: 10.1213/ANE.0000000000002658
  3. Babazade R., Vadhera R.B., Krishnamurthy P., et al. Acute postcesarean pain is associated with in-hospital exclusive breastfeeding, length of stay, and post-partum depression. Journal of Clinical Anesthesia. 2020; 62: 109697. DOI: 10.1016/j.jclinane.2019.109697
  4. Borges N.C., de Deus J.M., Guimarães R.A., et al. The incidence of chronic pain following Cesarean section and associated risk factors: A cohort of women followed up for three months. PLOS ONE. 2020; 15(9): e0238634. DOI: 10.1371/journal.pone.0238634
  5. Carvalho B., Butwick A.J. Postcesarean delivery analgesia. Best Practice & Research Clinical Anaesthesiology. 2017; 31(1): 69–79. DOI: 10.1016/j.bpa.2017.01.003
  6. Quinlan J. Caesarean delivery: Bringing more than just a bundle of joy. Canadian Journal of Pain. 2019; 3(2): 5–9. DOI: 10.1080/24740527.2019.1574538
  7. Veef E., Van de Velde M. Post-cesarean section analgesia. Best Practice & Research Clinical Anaesthesiology. 2022; 36(1): 83–8. DOI: 10.1016/j.bpa.2022.02.006
  8. Guevara J., Carvalho J.C.A., Downey K., et al. Predicting pain after Cesarean delivery: pressure algometry, temporal summation, three-item questionnaire. Canadian Journal of Anesthesia/Journal Canadien d’anesthésie. 2021; 68(12): 1802–10. DOI: 10.1007/s12630-021-02105-z
  9. Buhagiar L., Cassar O., Brincat M., et al. Pre-operative pain sensitivity: A prediction of postoperative outcome in the obstetric population. Journal of Anaesthesiology Clinical Pharmacology. 2013; 29(4): 465. DOI: 10.4103/0970-9185.119135
  10. Buhagiar L., Cassar O., Brincat M., et al. Predictors of post-caesarean section pain and analgesic consumption. Journal of Anaesthesiology Clinical Pharmacology. 2011; 27(2): 185. DOI: 10.4103/0970-9185.81822
  11. Невидимова Т.И., Бохан Н.А., Коконова Д.Н. Способ количественной оценки индивидуальных болевых порогов. 2008. [Patent RUS № 2342063/27.12.2008. Byul. № 36. Nevidimova T.I., Bokhan N.A., Kokonova D.N. Possibility of quantitative assessment of the properties of pain thresholds. Available from: https://www.freepatent.ru/patents/2342063. Accessed: 05.02.2024. (In Russ)] https://www.freepatent.ru/patents/2342063 (28.02.2024)
  12. Samuel H., Aweke S., Tuni J. Effect of low-dose intravenous ketamine on postoperative pain following cesarean section under spinal anesthesia: A prospective cohort study, Ethiopia. Annals of Medicine & Surgery. 2022; 77. DOI: 10.1016/j.amsu.2022.103570
  13. Heesen M., Bohmer J., Brinck E.C.V., et al. Intravenous ketamine during spinal and general anesthesia for caesarean section: systematic review and meta‐analysis. Acta Anaesthesiologica Scandinavica. 2015; 59(4): 414–26. DOI: 10.1111/aas.12468
  14. Шиндяпина Н.В., Шифман Е.М., Маршалов Д.В. и др. Клинические эффекты низких доз кетамина в раннем послеоперационном периоде кесарева сечения (метаанализ). Анестезиология и реаниматология. 2021; 2: 19–35. DOI: 10.17116/anaesthesiology202102119 [Shindyapina N.V., Marshalov D.V., Shifman E.M., et al. Clinical effect of low-dose ketamine in early postoperative period after caesarean section (meta-analysis). Russian Journal of Anaesthesiology and Reanimatology. 2021; 2: 19–35. DOI: 10.17116/anaesthesiology202102119 (In Russ)]
  15. Lachin J.M. Introduction to sample size determination and power analysis for clinical trials. Controlled Clinical Trials. 1981; 2(2): 93–113. DOI: 10.1016/0197-2456(81)90001-5
  16. Rahmanian M., Leysi M., Hemmati A.A., et al. The Effect of Low-Dose Intravenous Ketamine on Postoperative Pain Following Cesarean Section with Spinal Anesthesia: A Randomized Clinical Trial. Oman Medical Journal. 2015; 30(1): 11–6. DOI: 10.5001/omj.2015.03
  17. Wang J., Xu Z., Feng Z. Impact of Ketamine on Pain Management in Cesarean Section: A Systematic Review and Meta-Analysis. Pain Physician. 2020; 23(2): 135–48. DOI: 10.36076/ppj.2020/23/135
  18. Kose E.A., Honca M., Dal D., et al. Prophylactic ketamine to prevent shivering in parturients undergoing Cesarean delivery during spinal anesthesia. Journal of Clinical Anesthesia. 2013; 25(4): 275–80. DOI: 10.1016/j.jclinane.2012.11.014
  19. Stoker A.D., Rosenfeld D.M., Buras M.R., et al. Evaluation of Clinical Factors Associated with Adverse Drug Events in Patients Receiving Sub-Anesthetic Ketamine Infusions. Journal of Pain Research. 2019; 12: 3413–21. DOI: 10.2147/JPR.S217005
  20. Modir H., Moshiri E., Kamali A., et al. Prophylactic efficacy of dexamethasone, ketamine, and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery. 2019; 52(1): 17–23. DOI: 10.4103/fjs.fjs_37_18
  21. Shabana A.M., Nasr E.S., Moawad H.E. Effect of ketamine on intraoperative nausea and vomiting during elective caesarean section under spinal anaesthesia: A placebo-controlled prospective randomized double-blinded study. Egyptian Journal of Anaesthesia. 2012; 28(2): 169–74. DOI: 10.1016/j.egja.2012.02.001
  22. Lema G.F., Gebremedhn E.G., Gebregzi A.H., et al. Efficacy of intravenous tramadol and low-dose ketamine in the prevention of post-spinal anesthesia shivering following cesarean section: a double-blinded, randomized control trial. International Journal of Women’s Health. 2017; 9: 681–8. DOI: 10.2147/IJWH.S139655
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2024 Annals of Critical Care